Activating PKC-ε induces HIV expression with improved tolerability.
Saved in:
| Title: | Activating PKC-ε induces HIV expression with improved tolerability. |
|---|---|
| Authors: | Irrinki AM; Gilead Sciences, Inc., Foster City, California, United States of America., Kaur J; Gilead Sciences, Inc., Foster City, California, United States of America., Randhawa B; Gilead Sciences, Inc., Foster City, California, United States of America., McFadden R; Gilead Sciences, Inc., Foster City, California, United States of America., Snyder C; Gilead Sciences, Inc., Foster City, California, United States of America., Truong H; Gilead Sciences, Inc., Foster City, California, United States of America., Soohoo D; Gilead Sciences, Inc., Foster City, California, United States of America., Hu E; Gilead Sciences, Inc., Foster City, California, United States of America., Yu H; Gilead Sciences, Inc., Foster City, California, United States of America., Murray BP; Gilead Sciences, Inc., Foster City, California, United States of America., Lu B; Gilead Sciences, Inc., Foster City, California, United States of America., Kornyeyev D; Gilead Sciences, Inc., Foster City, California, United States of America., Irwan ID; Gilead Sciences, Inc., Foster City, California, United States of America., Nguyen L; Gilead Sciences, Inc., Foster City, California, United States of America., Yang YS; Gilead Sciences, Inc., Foster City, California, United States of America., Belzile JP; Gilead Sciences, Inc., Foster City, California, United States of America., Schmitz U; Gilead Sciences, Inc., Foster City, California, United States of America., Appleby TC; Gilead Sciences, Inc., Foster City, California, United States of America., Schultz B; Gilead Sciences, Inc., Foster City, California, United States of America., Lalezari J; Quest Clinical Research, San Francisco, California, United States of America., Deeks S; Department of Medicine, University of California, San Francisco, San Francisco, California, United States of America., Cihlar T; Gilead Sciences, Inc., Foster City, California, United States of America., Murry JP; Gilead Sciences, Inc., Foster City, California, United States of America. |
| Source: | PLoS pathogens [PLoS Pathog] 2025 Feb 06; Vol. 21 (2), pp. e1012874. Date of Electronic Publication: 2025 Feb 06 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7374 (Electronic) Linking ISSN: 15537366 NLM ISO Abbreviation: PLoS Pathog Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39913544 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Activating PKC-ε induces HIV expression with improved tolerability. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Irrinki+AM%22">Irrinki AM</searchLink>; Gilead Sciences, Inc., Foster City, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Kaur+J%22">Kaur J</searchLink>; Gilead Sciences, Inc., Foster City, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Randhawa+B%22">Randhawa B</searchLink>; Gilead Sciences, Inc., Foster City, California, United States of America.<br /><searchLink fieldCode="AU" term="%22McFadden+R%22">McFadden R</searchLink>; Gilead Sciences, Inc., Foster City, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Snyder+C%22">Snyder C</searchLink>; Gilead Sciences, Inc., Foster City, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Truong+H%22">Truong H</searchLink>; Gilead Sciences, Inc., Foster City, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Soohoo+D%22">Soohoo D</searchLink>; Gilead Sciences, Inc., Foster City, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Hu+E%22">Hu E</searchLink>; Gilead Sciences, Inc., Foster City, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Yu+H%22">Yu H</searchLink>; Gilead Sciences, Inc., Foster City, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Murray+BP%22">Murray BP</searchLink>; Gilead Sciences, Inc., Foster City, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Lu+B%22">Lu B</searchLink>; Gilead Sciences, Inc., Foster City, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Kornyeyev+D%22">Kornyeyev D</searchLink>; Gilead Sciences, Inc., Foster City, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Irwan+ID%22">Irwan ID</searchLink>; Gilead Sciences, Inc., Foster City, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Nguyen+L%22">Nguyen L</searchLink>; Gilead Sciences, Inc., Foster City, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Yang+YS%22">Yang YS</searchLink>; Gilead Sciences, Inc., Foster City, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Belzile+JP%22">Belzile JP</searchLink>; Gilead Sciences, Inc., Foster City, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Schmitz+U%22">Schmitz U</searchLink>; Gilead Sciences, Inc., Foster City, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Appleby+TC%22">Appleby TC</searchLink>; Gilead Sciences, Inc., Foster City, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Schultz+B%22">Schultz B</searchLink>; Gilead Sciences, Inc., Foster City, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Lalezari+J%22">Lalezari J</searchLink>; Quest Clinical Research, San Francisco, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Deeks+S%22">Deeks S</searchLink>; Department of Medicine, University of California, San Francisco, San Francisco, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Cihlar+T%22">Cihlar T</searchLink>; Gilead Sciences, Inc., Foster City, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Murry+JP%22">Murry JP</searchLink>; Gilead Sciences, Inc., Foster City, California, United States of America. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101238921%22">PLoS pathogens</searchLink> [PLoS Pathog] 2025 Feb 06; Vol. 21 (2), pp. e1012874. <i>Date of Electronic Publication: </i>2025 Feb 06 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101238921 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1553-7374 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215537366%22">15537366 </searchLink><i>NLM ISO Abbreviation: </i>PLoS Pathog <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39913544 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1371/journal.ppat.1012874 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e1012874 Titles: – TitleFull: Activating PKC-ε induces HIV expression with improved tolerability. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Irrinki AM – PersonEntity: Name: NameFull: Kaur J – PersonEntity: Name: NameFull: Randhawa B – PersonEntity: Name: NameFull: McFadden R – PersonEntity: Name: NameFull: Snyder C – PersonEntity: Name: NameFull: Truong H – PersonEntity: Name: NameFull: Soohoo D – PersonEntity: Name: NameFull: Hu E – PersonEntity: Name: NameFull: Yu H – PersonEntity: Name: NameFull: Murray BP – PersonEntity: Name: NameFull: Lu B – PersonEntity: Name: NameFull: Kornyeyev D – PersonEntity: Name: NameFull: Irwan ID – PersonEntity: Name: NameFull: Nguyen L – PersonEntity: Name: NameFull: Yang YS – PersonEntity: Name: NameFull: Belzile JP – PersonEntity: Name: NameFull: Schmitz U – PersonEntity: Name: NameFull: Appleby TC – PersonEntity: Name: NameFull: Schultz B – PersonEntity: Name: NameFull: Lalezari J – PersonEntity: Name: NameFull: Deeks S – PersonEntity: Name: NameFull: Cihlar T – PersonEntity: Name: NameFull: Murry JP IsPartOfRelationships: – BibEntity: Dates: – D: 06 M: 02 Text: 2025 Feb 06 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1553-7374 Numbering: – Type: volume Value: 21 – Type: issue Value: 2 Titles: – TitleFull: PLoS pathogens Type: main |
| ResultId | 1 |